Lignocainum Hydrochloricum Wzf

Lidocaine hydrochloride, the active ingredient in Lignocainum Hydrochloricum Wzf, is a local anesthetic presented as a sterile solution for epidural, infiltration, and intrathecal use. It provides reversible nerve block for procedures that require regional anesthesia in adult patients.

GNH USA supplies Lignocainum Hydrochloricum Wzf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lignocainum Hydrochloricum Wzf is a local anesthetic used in procedures that involve regional nerve blockade.

- Epidural procedures: provides local anesthesia for pain control during epidural administration. - Infiltration procedures: creates a temporary loss of sensation in targeted tissue for minor surgeries or diagnostic work. - Intrathecal procedures: delivers spinal anesthesia to facilitate surgeries or pain management interventions.

Lignocainum Hydrochloricum Wzf may cause a range of adverse reactions following administration.

Common Side Effects: - Tingling or numbness at the injection site. - Metallic taste in the mouth. - Light‑headedness or dizziness. - Mild hypotension. - Transient visual disturbances.

Serious or Rare Side Effects: - Seizures or convulsions. - Cardiac arrhythmias, including ventricular tachycardia. - Severe hypotension or cardiovascular collapse. - Allergic reactions such as rash, bronchospasm, or anaphylaxis. - Central nervous system depression leading to respiratory compromise.

When using Lignocainum Hydrochloricum Wzf, clinicians should observe several safety measures.

- Assess patient allergy: verify no known hypersensitivity to lidocaine or amide‑type anesthetics. - Monitor cardiovascular status: watch for hypotension, bradycardia, or arrhythmias during and after injection. - Use the lowest effective dose: limit exposure to reduce risk of systemic toxicity. - Avoid intravascular injection: aspirate before administration to prevent rapid systemic absorption. - Use caution in hepatic impairment: reduced metabolism may increase plasma levels. - Store at room temperature: keep in the original container, protect from moisture and light.

Lignocainum Hydrochloricum Wzf can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): increase risk of systemic lidocaine toxicity. - Beta‑blockers (e.g., propranolol): may enhance cardiotoxic effects of lidocaine. - Strong CYP3A4 inhibitors (e.g., ketoconazole): raise plasma lidocaine concentrations.

Moderate Interactions (Monitor Closely): - Alpha‑2 agonists (e.g., clonidine): additive hypotensive effect. - General anesthetics (e.g., propofol): may potentiate central nervous system depression. - Loop diuretics (e.g., furosemide): may alter lidocaine clearance and plasma levels.